Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Just an FYI . . . Grewal denied TPL's motion to continue the trial.
ORDER DENYING TPL’S MOTION TO CONTINUE TRIAL Defendants Technology Properties Ltd., et al, (“TPL”) move to continue the trial date in this case from June 24, 2013 to October 21, 2013 because of obligations in a parallel proceeding TPL brought in the U.S. International Trade Commission (“ITC”). Plaintiffs Acer, Inc., et al, and HTC Corp., et al, (“Plaintiffs”) oppose. Having considered the many delays this case already has faced and the court’s own congested schedule, the court reluctantly DENIES TPL’s motion. Obviously, the court is eager to accommodate conflicts counsel face in managing multiple litigations. But that is simply not possible here. The dates set in the September 14, 2012 scheduling order remain unchanged. IT IS SO ORDERED. Dated: December 18, 2012
Share
New Message
Please login to post a reply